<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">2808</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> http://dx.doi.org/10.31782/IJCRR.2020.121513</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Efficacy of Ayurvedic Formulations along with Swedana Therapy in the Management of Amavata (Rheumatoid Arthritis) - A Clinical Study&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wairagade</surname><given-names>Sonali Dilip</given-names></name></contrib><contrib contrib-type="author"><name><surname>Nagrare</surname><given-names>Anuja Vasant</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wairagade</surname><given-names>Tanvi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Chandi</surname><given-names>Dhuba Hari</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>8</day><month>08</month><year>2020</year></pub-date><volume>5)</volume><issue/><fpage>79</fpage><lpage>87</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Amavata is a disease in which vitiation of Vata Dosha and accumulation of Ama take place in joint(s), and it simulates rheumatoid arthritis (RA) at modern phraseology. Shamana (conservative) and Shodhana (biological purification of the body) treatments are advised in Ayurveda whereas anti-inflammatory, analgesics, steroids, and disease modifying antirheumatic drugs are required for its management as per modern medicine, which is not free from side effects. The symptoms of Amavata are alike to Rheumatism, which include Rheumatoid arthritis and Rheumatic fever. It is observed that Rheumatism is an autoimmune disorder, which is among the collagen disorders having strong and significant parlance with Amavata. A variety of drug trials were already carried out on Amavata, yet there is a lacuna in the management of Amavata. Hence the present study was designed to calculate the effectiveness of Ayurvedic formulations in Amavata. The study was conducted in 15 clinically diagnosed cases of Amavata (Rheumatoid Arthritis) with objectives of Clinical Evaluation of Therapeutic Effect of Rasnadikashayam 3 t.s.f. thrice/day, Sahachradikashayam 3 t.s.f. once/day, Amvatari Ras 2 tabs once/day were given for 3 months and Erand tail __ampersandsignfrac12; t.s.f.once/day at night were given for 1 month along with Swedan therapy in patients of Amavata (Rheumatoid Arthritis) on the basis of various scientific parameters. Patients were treated with the whole therapeutic regime mentioned in Ayurvedic classics i.e., Langhana, Swedana, use of Tikta, Katu, and Deepan dravyaprayoga, Virechan. The effect of the therapy was assessed by a specially prepared proforma and at the end of the treatment, 39.39% improvement was observed in the overall effect of therapy. Paired t-test was applied to this BT and AT scores as these grades is accepted as per international norms. It showed that administered therapy reduced the degree of disease activity significantly as P __ampersandsignlt; 0.001.&#13;
</p></abstract><kwd-group><kwd>Ama</kwd><kwd> Amavata</kwd><kwd> Rasnadikashayam</kwd><kwd> Sahachradikashayam</kwd><kwd> Amvatari Ras</kwd><kwd> Gandharvahastadi Erand tail</kwd><kwd> Swedan</kwd><kwd> Vata</kwd><kwd> Rheumatoid arthritis</kwd><kwd> Clinical trial</kwd></kwd-group></article-meta></front></article>
